Patents Assigned to Baxter Vaccine AG
  • Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
    Patent number: 6872550
    Abstract: A novel approach to Borrelia vaccine formulation taking into account serological, genotypic and epidemiological information by which OspC proteins from different strains of B. burgdorferi are grouped together. OspC antigens are chosen in order to constitute a representative sample of such groupings, so that the resulting vaccine provides the greatest cross-protectivity with the fewest number of antigens.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: March 29, 2005
    Assignee: Baxter Vaccine AG
    Inventors: Ian Livey, Brian Crowe, Friedrich Dorner
  • Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
    Patent number: 6486130
    Abstract: A novel approach to Borrelia vaccine formulation taking into account serological, genotypic and epidemiological information by which OspC proteins from different strains of B burgdorferi are grouped together. OspC antigens are chosen in order to constitute a representative sample of such groupings, so that the resulting vaccine provides the greatest cross-protectivity with the fewest number of antigens.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: November 26, 2002
    Assignee: Baxter Vaccine AG
    Inventors: Ian Livey, Brian Crowe, Friedrich Dorner
  • Chimeric poxvirus comprising sequences of a retroviral vector component
    Patent number: 6352856
    Abstract: A chimeric poxvirus is disclosed, which comprises the sequences of the vector component of a retroviral vector particle and optionally the packaging component of a defective retroviral particle. The chimeric poxvirus according to the invention particularly can be used for applications in gene therapy or tumor therapy.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: March 5, 2002
    Assignee: Baxter Vaccine AG
    Inventors: Falko-Guenter Falkner, Georg Holzer, Friedrich Dorner